Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: France Clear all

227 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20026
20036
20046
20059
200614
200717
200816
200912
201012
20119
20129
201313
201410
201515
20166
20177
20184
201911
20205
20213
20224
20234
20248
20257
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed145
Terminated36
Recruiting18
Active, not recruiting11
Unknown status10
Withdrawn5
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UNICANCER22
Hoffmann-La Roche18
Pfizer9
European Organisation for Research and Treatment of Cancer - EORTC8
GlaxoSmithKline8
Novartis Pharmaceuticals8
ARCAGY/ GINECO GROUP7
Centre Jean Perrin7
Sanofi7
AstraZeneca6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms227
Neoplasm Metastasis32
Neoplasms14
Triple Negative Breast Neoplasms9
Brain Neoplasms8
Ovarian Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Colorectal Neoplasms6
Sarcoma5
Head and Neck Neoplasms4

Trials

Showing 1 to 25 of 227. Each trial links to its page on Pharma Observatory.

127 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.